Depression Drugs Market 2018 Competitive analysis of Top key players Actavis, Addex Therapeutics, Alkermes, Allergan Inc., AstraZeneca, Bristol-Myers Squibb and more top players

Competitive Research Study on Depression Drugs market status and forecast, categorizes the global Cable Glands market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in United States, Europe, China, Japan, South Korea and Taiwan and other regions.
Depression Drugs market Report by Application, and Geography – Global Forecast to 2024 is a professional and in-depth research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China).
Download FREE Sample of this Report at
Scope of Global Depression Drugs Market Reports
As per WHO, depression is a common mental disorder includes brain that contributes significantly to the global burden of disease. Depression is a serious mood disorder which causes a tenacious feeling of sadness and loss of interest therefore affecting daily routine activities such as sleeping, walking, talking, thinking and eating. Depression is a mental health issue. It is a condition that begins more often in initial stages of adulthood. Also, it is more commonly observe in women. Though, anyone at any age may get suffer from depression. Depression affects the brain so drugs that work in the brain called ‘Antidepressant Drugs’. General antidepressants can decrease symptoms, but there are many other options to reduce the depression. Each drug used to treat depression by balancing certain chemicals in brain known as ‘Neurotransmitters’. Signs and symptoms of depression differ from individual to individual on the basis of risk factors, individual thinking and lifestyle. It includes sadness, irritability, loss of attention in daily routine activities, feelings of pessimism, guilt, social withdrawal, fatigue, insomnia, loss of appetite, headache, cramps, digestive problems, weight loss or gain, restlessness and suicide attempts. Also, alcoholism and drug abuse may be the signs of depression. Likewise there are different types of depression which has distinctive characteristics such as persistent depressive disorder, perinatal depression disorder, psychotic depression, Seasonal affective disorder and bipolar depression. Depression is also classified based on its severity as mild, moderate and severe. An individual with severe depression can have suicidal thoughts and behaviors. According to 2012estimation by the WHO around 3,000 suicides take place per day, resulting in more than a million deaths each year. Depression can be recurring and can be severely debilitating. Patients with mild depression can be treated with medications but in moderate or severe depression cases, the patient needs both medication and professional psychotherapy in the form of counseling.
The Global Depression Drugs Market is segmented on the basis of Drug type, Disease Type, Distribution channel, and Geography. On the basis of Drug type Global Depression Drugs Market is divided into Tricyclic Antidepressants, Serotonin-Norepinephrine Inhibitors, Atypical Antipsychotics, Selective Serotonin Reuptake Inhibitors, Benzodiazepines, Tetracyclic Antidepressants, Monoamine Oxidase Inhibitors and Others. On the basis of Disease Type Global Depression Drugs Market is divided into Major Depressive Disorder, Schizophrenia, Bipolar I Disorder, Selective Serotonin Reuptake Inhibitor Induced Disorder and other. On the basis of Distribution channel Global Depression Drugs Market is divided into Hospital pharmacies, Retail pharmacies, Online pharmacies, Clinics and Research centers.
Global Depression Drugs Market Regional Analysis

Geographically, North America accounted for the largest market share of around 37.20% in 2016; due to high patient awareness levels regarding availability of various antidepressant drugs for increasing healthcare expenditure and relatively larger number of Research & Development affecting to drug manufacturing and marketing etc. These factors contribute for significant revenue generation from the region. Europe have the second largest share of the Global Depression Drugs Market in 2017, which can be recognized to the increase in research and development activities on depression drugs in the region. Asia-Pacific is to attain the fastest CAGR during the forecast period, owed to increased demand from developing countries such as China, Japan, and Australia. An initiative by the local government to reach self-sufficiency in the manufacturing of Antidepressant drugs and increasing awareness amongst consumers regarding benefits of Antidepressant drug is also likely to boost the growth of Global Depression Drugs Market in the region.
Top manufacturers covered in this report
• Actavis
• Addex Therapeutics
• Alkermes
• Allergan Inc.
• AstraZeneca
• Bristol-Myers Squibb
• Cerecor
• Dart NeuroScience
• Reddy’s Laboratories
• Edgemont Pharmaceuticals
• Eli Lilly and Company
• Euthymics
• Fabre Kramer
• Forest Laboratories
• Gedeon Richter
• Intellipharmaceutics
• Intra-Cellular Therapies
• Janssen Pharmaceuticals
• Johnson & Johnson
• Kanghong Pharma
• Lundbeck
• Lupin
• Luye Pharma
• Merck & Co.
• MSI Methylation Sciences
• Naurex
• NHU Group
• Novartis AG, GlaxoSmithKline
• Opko Health
• Otsuka Pharmaceutical Co.Ltd.
• Pfizer Inc.
• Sebela Pharmaceutical Inc.
• Shionogi
• Shire
• SK Biopharmaceuticals
• Somerset Pharmaceuticals
• Sun Pharmaceutical
• Sunovion Pharmaceuticals
• Takeda Pharmaceutical Company Ltd
• Torrent Pharmaceuticals
• Valeant Pharmaceuticals
• Others
On the basis of Regional & Country Analysis
• North America
• U.S.
• Mexico
• Canada
• Europe
• UK
• France
• Germany
• Italy
• Asia Pacific
• China
• Japan
• India
• Southeast Asia
• Latin America
• Brazil
• The Middle East and Africa
• Africa
• Rest of Middle East and Africa
On the basis of Drug type Analysis
• Tricyclic Antidepressants
• Serotonin-Norepinephrine Inhibitors
• Atypical Antipsychotics
• Selective Serotonin Reuptake Inhibitors
• Benzodiazepines
• Tetracyclic Antidepressants
• Monoamine Oxidase Inhibitors
• Other
On the basis of Distribution channel Analysis
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies
• Clinics
• Research centers
• Other
On the basis of Disease Type Analysis
• Major Depressive Disorder
• Schizophrenia
• Bipolar I Disorder
• Selective Serotonin Reuptake Inhibitor Induced Disorder
• Other
Key Benefits for Global Depression Drugs Market Reports –
• Global Depression Drugs Market report covers in depth historical and forecast analysis.
• Global Depression Drugs Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
• Global Depression Drugs Market report helps to identify opportunities in market place.
• Global Depression Drugs Market report covers extensive analysis of emerging trends and competitive landscape.
Our Market Research Solution Provides You Answer to Below Mentioned Question:
• Where to invest? (Country and region specific)
• How will the market shares of the national markets change by 2024 and which geographical region will lead the market in 2024?
• Who are top players of this market?
• How much revenue is generating by each market players?
• How many products have been sold by each market players?
• What is the price and gross margin?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2018 and 2024?
• Which product type has more potential to drive the market and it helps to understand where to invest?
• How will the industry evolve during the period between 2014 and 2024?
• How will the market shares of the regional and country markets change by 2024 and which geographical region will lead the market in 2024?
• How will the industry evolve during the period between 2014 and 2024?
• Which are the products served by each market players?
• What is the strategy used to remain competent in market by leading players?
• What are the key strength and weakness of leading players?
Why you should buy this report:
• To receive a comprehensive analysis of the prospects for global dental equipment market
• To receive forecasts of global dental equipment market sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions
• To discover the views of experts in the Global Dental Equipment Market sector
• To determine the forces and factor that influences the market for Global Dental Equipment Market: drivers, restraints, opportunities and threats
• To find out where the global dental equipment market is heading – both technologically and commercially from 2018-2024
• Report Include tables of contract/projects and its value and description by region and Country
Browse our full report with Table of Contents at
About Us:
We publish market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London. Contact us at +44-2038074155 or mail us at
Follow us on LinkedIn
Follow us on Twitter
Follow us on Facebook:
Follow us on Pinterest:
Follow us on Instagram:
Follow us on Google+: